Last update:
Medications news
Medications
Q&A: Could a new drug help prevent heart attacks and strokes?
A new drug in clinical trials is showing promise in lowering a key genetic risk factor for heart attacks and strokes—something no existing treatment has been able to do.
16 minutes ago
0
0
Medications
Survey: One in three supplements contain banned substances
Sport Integrity Australia (SIA) has released the findings of a major survey of sports supplements available in the Australian online marketplace, revealing a significant and continuing risk for athletes. The results are published ...
15 minutes ago
0
0
Tackling the 'silent pandemic': Study puts first long COVID treatment on horizon
Researchers have shown a new drug compound can prevent long COVID symptoms in mice—a landmark finding that could lead to a future treatment for the debilitating condition.
23 hours ago
0
208
Novel drug compound offers safer alternative for pain relief by targeting specific receptors
University of Florida scientists have helped identify a novel drug compound that selectively activates pain-altering receptors in the body, offering a potentially safer alternative to conventional pain medications.
21 hours ago
0
2
Trial is the first to show a delay in confirmed disability progression in non-relapsing secondary progressive MS
A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, demonstrated a 31% delay ...
23 hours ago
0
2
Tavapadon as adjunct to levodopa increases daily ON time in Parkinson's disease
For patients with Parkinson's disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases total daily ON time versus placebo, according to a ...
20 hours ago
0
1
Semaglutide may raise risk for nonarteritic anterior ischemic optic neuropathy in diabetes
For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online March 27 in JAMA Ophthalmology.
21 hours ago
0
0
Treatment-resistant depression responds better to esketamine with SNRI than SSRI, study finds
Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of disability and low quality of life. One in every three people suffering from MDD also has to deal with ...
ALS drug effectively treats Alzheimer's disease in animal study
Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS)—improves neuron health in animal models ...
Apr 8, 2025
0
14
Novel drug shows success for previously incurable advanced pulmonary hypertension
Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular changes cause the small pulmonary arteries to narrow. As a result, the right side of the heart has to ...
Apr 7, 2025
0
50
Hope, caution for Washington state patients 'first in line' for new schizophrenia drug
Cobenfy was approved by the Food and Drug Administration in fall 2024 and represents the first novel approach in decades to treating schizophrenia, which affects an estimated 3.7 million American adults. The drug is now beginning ...
Apr 7, 2025
0
97
Drug combo offers hope for advanced bladder cancer patients
Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary bladder and the upper part of the urethra. In the vast majority of cases, urothelial carcinomas ...
Apr 7, 2025
0
1
Five things to know about semaglutide-based medications and addiction treatment
Ozempic and similar semaglutide-based medications have been hailed as miracle drugs. Known as GLP-1 (glucagon-like peptide-1) agonists, this class of medications mimics a natural hormone the small intestine releases after ...
Apr 7, 2025
0
0
Animal tranquilizers found in illegal opioids may suppress the lifesaving medication naloxone
The animal tranquilizers xylazine and medetomidine are in approximately one-third of the illegal opioids available in the U.S., including fentanyl, heroin and oxycodone. Animal tranquilizers enhance the user's euphoric high ...
Apr 7, 2025
0
0
Local access to abortion services expanded with mifepristone in community pharmacies, Canadian study finds
Before 2017, abortions were generally performed as procedures in fewer than 100 hospitals and clinics mostly in urban centers, leading to delayed care, particularly for people living in rural areas. Medication abortions, ...
Apr 7, 2025
0
0
Study exposes huge levels of untargeted antibiotic prescribing
Doctors are prescribing antibiotics for tens of thousands of patients with infections, with little or no consideration of prognosis and the risk of the infection worsening, according to a new study led by University of Manchester ...
Apr 3, 2025
0
61
A failed fragile X syndrome drug can reduce cocaine use, clinical trial finds
A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has found that the drug mavoglurant can reduce use in people with cocaine use disorder. In their study, ...
AI-powered database spotlights medication risks to improve drug safety
A multicenter study led by Cedars-Sinai created a database of adverse medication events—the fourth leading cause of death in the United States and a medical issue costing more than $500 billion annually.
Apr 3, 2025
0
25
Q&A: How can drug repurposing lower drug costs and improve care?
Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United States topped $722 billion, a trend that's expected to continue. Yet, nearly 30% struggle to pay for their prescriptions ...
Apr 3, 2025
0
0
Robots can aid hospital pharmacies in safer and more sustainable cancer drug preparation
Can a robot help prepare cancer medication in a hospital pharmacy? That's what hospital pharmacist Tjerk Geersing investigated in his Ph.D. research. He compared manual and automated preparations in terms of quality, efficiency, ...
Apr 3, 2025
0
0
FDA approves Qfitlia to cut bleeding episodes in patients with hemophilia
The U.S. Food and Drug Administration has approved Sanofi's Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with ...
Apr 3, 2025
0
0
New COVID-19 drug shows greater promise against resistant viral strains
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.
Apr 2, 2025
0
254
Common photosensitizing drugs increase skin cancer risk, study indicates
Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.
Apr 2, 2025
0
0
Use of last-resort antibiotics increased during COVID-19 pandemic
A new study by researchers from City St George's, University of London and the Ineos Oxford Institute for antimicrobial research, has found that prescriptions of last-resort antibiotics increased across multiple countries ...
Apr 2, 2025
0
0
Novel Alzheimer's drug candidate reduces inflammation and protects neurons
Alzheimer's disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited efficacy and only in mild stages of the disease. A team from the University of Barcelona has developed ...
Apr 1, 2025
0
61
